BioNTech SE: xbrl:AdjustmentsForSharebasedPayments
| Value | {"unit": "EUR", "value": 80500000} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | superseded |
| Entity | BioNTech SE |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/59d95b63-b211-4387-b52b-4429f5d7cf48
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001776985-22-000019Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/59d95b63-b211-4387-b52b-4429f5d7cf48
History
- no predecessors — first report